{"0": "Glycosaminoglycan degradation", "1": "Sphingolipid metabolism in senescence", "2": "Sphingolipid metabolism overview", "3": "Sphingolipid metabolism integrated pathway", "4": "Ferroptosis", "5": "Sphingolipid pathway", "6": "Alzheimers disease", "7": "Alzheimers disease and mirna effects", "8": "Mitochondrial complex iv assembly", "9": "Metapathway biotransformation phase i and ii", "10": "Nonalcoholic fatty liver disease", "11": "Cholesterol metabolism with bloch and kandutschrussell pathways", "12": "Proteasome degradation", "13": "Nrf2 pathway", "14": "Hepatitis b infection", "15": "Electron transport chain oxphos system in mitochondria", "16": "Cholesterol biosynthesis pathway", "17": "Network map of sarscov2 signaling pathway", "18": "Sterol regulatory elementbinding proteins srebp signaling", "19": "Spinal cord injury", "20": "G1 to s cell cycle control", "21": "Fragile x syndrome", "22": "Mitochondrial complex i assembly model oxphos system", "23": "Nuclear receptors metapathway", "24": "Small cell lung cancer", "25": "Oxidative phosphorylation", "26": "Nucleotide excision repair", "27": "Il18 signaling pathway", "28": "Mecp2 and associated rett syndrome", "29": "Angiopoietinlike protein 8 regulatory pathway", "30": "Sarscov2 innate immunity evasion and cellspecific immune response"}